Login / Signup

Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland.

Katarzyna GorskaMarta Maskey-WarzęchowskaMałgorzata BarnaśAdam BiałasAdam BarczykHanna Jagielska-LenEwa JassemAleksander KaniaKatarzyna LewandowskaSebastian MajewskiMagdalena M Martusewicz-BorosWojciech J PiotrowskiAlicja SiemińskaKrzysztof SładekMałgorzata SobieckaMarzena Trzaska-SobczakWitold TomkowskiBeata ŻołnowskaRafał Krenke
Published in: Therapeutic advances in chronic disease (2022)
, and history of gastrointestinal bleeding were significant factors influencing the decision to initiate antifibrotic therapy.
Keyphrases
  • idiopathic pulmonary fibrosis
  • cross sectional
  • interstitial lung disease
  • decision making
  • double blind
  • clinical trial
  • rheumatoid arthritis
  • mesenchymal stem cells